NCT02092324 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02092324
Title	Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	OHSU Knight Cancer Institute
Indications	chronic neutrophilic leukemia chronic myeloid leukemia
Therapies	Ruxolitinib
Age Groups:	adult \| senior
Covered Countries	USA

Filter rows:

Showing 1 to 7 of 7 entries

Facility	City	State	Zip	Country	Details
Emory University Hospital/Winship Cancer Institute	Atlanta	Georgia	30322	United States	Details
Huntsman Cancer Institute/University of Utah	Salt Lake City	Utah	84112	United States	Details
M D Anderson Cancer Center	Houston	Texas	77030	United States	Details
OHSU Knight Cancer Institute	Portland	Oregon	97239	United States	Details
Stanford Cancer Institute Palo Alto	Palo Alto	California	94304	United States	Details
UT Southwestern/Simmons Cancer Center-Dallas	Dallas	Texas	75390	United States	Details
Washington University School of Medicine	Saint Louis	Missouri	63110	United States	Details

Showing 1 to 7 of 7 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT02092324Clinical Trial Detail